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Steroid nasal kini merupakan rawatan yang paling berkesan untuk ‘allergic rhinitis’ (AR) dan 
merupakan terapi pertama untuk orang dewasa dalam kes-kes ‘allergic rhinitis’ yang sederhana-ke-
parah atau pada individu yang masih simptomatik walaupun sentiasa menggunakan ubatan 
antihistamin . Walaupun steroid nasal adalah rawatan AR yang paling biasa digunakan, kurang 
daripada separuh pesakit  berpuas hati dengan nasal steroid mereka. Kebanyakan pesakit berhenti 
rawatan kerana kekurangan kelegaan berpanjangan dan pelbagai sebab lain. Walaupun terdapat 
banyak kajian dan penghargaan terhadap kepentingan klinikal penggunaan nasal steroid untuk 
pesakit AR, penyelidikan di kawasan ini telah dihalang oleh ketiadaan soal selidik yang dikhaskan 
untuk penilaian diri terhadap pengetahuan, sikap dan amalan pesakit AR terhadap penggunaan 
steroid nasal. Kajian ini direka untuk menilai pengetahuan, sikap dan amalan pesakit ‘allergic 
rhinitis’ terhadap penggunaan steroid nasal. 
 
Kaedah: 
Kajian soal selidik ini dijalankan di dua buah hospital besar. Proses ini terdiri daripada peringkat 
pembentukan dan pengesahan. Fasa pembentukan merangkumi kajian literatur, komen panel pakar, 
ujian kumpulan fokus, dan penilaian soal selidik yang dibentukkan. Tahap pengesahan terdiri 
daripada pengesahan kandungan, pengesahan parasan, kesahihan pembinaan, analisis faktor 
penerokaan dan kaedah uji selidik. Cronbach’s alpha digunakan untuk mengesahkan konsistensi 
dalaman. Versi akhir yang disemak telah dirangka. Segmen pengetahuan terdiri daripada lima 






Seramai 77 peserta telah mendaftar. Dua puluh daripadanya (26%) mempunyai simtom ‘mild 
intermittent’, 32 (41.6%) mempunyai simtom ‘mild persistent’ dan 25 (32.5%) mempunyai simtom 
‘moderate severe persistent AR’. Sembilan puluh lima peratus menyatakan mereka memahami 
soalan-soalan dan mendapati mereka mudah dijawab. Sembilan puluh peratus menunjukkan 
penampilan dan susun aturan yang boleh diterima. Analisis faktor penjelasan mendedahkan empat 
faktor yang dikaitkan dengan KAP. Cronbach’s alpha dari empat faktor adalah dari 0.614 dan 
0.809. Soal selidik akhir yang terdiri daripada segmen pengetahuan terdiri daripada empat soalan, 




Soal selidik ini mempunyai kebolehpercayaan yang memuaskan dan indeks kesahan dan boleh 
digunakan untuk mengukur pengetahuan, sikap dan amalan pesakit AR mengenai penggunaan nasal 
steroid. Kajian ini boleh membangkitkan pengetahuan, sikap dan amalan di kalangan pesakit AR 
untuk lebih memahami dan seterusnya meningkatkan hasil rawatan dengan mendidik pesakit dan 













Intranasal corticosteroids (INCS) are presently the most effective overall treatment for allergic 
rhinitis (AR) and are first-line therapy for adults in moderate-to-severe cases of allergic rhinitis or 
in individuals who are still symptomatic despite the regular use of antihistamines. Although INCS 
are the most commonly prescribed AR treatment, less than half of patients are fully satisfied with 
their INCS. Most patients discontinue treatment due to lack of long-lasting symptom relief and 
other various reasons side. In spite of numerous studies and the appreciation of the clinical 
importance of INCS usage for AR patients, research in this area has been impeded by absence of a 
questionnaire devoted to an assessment of self-reported evaluation of knowledge, attitude and 
practice of AR patients towards INCS usage. This study was designed to assess the knowledge, 
attitude and practice (KAP) of allergic rhinitis patients towards intranasal corticosteroids usage. 
 
Methods:  
This cross-sectional questionnaire study was conducted in two tertiary hospitals. The process 
comprised of development and validation stages. The development phase encompassed a literature 
review, expert panel review, focus group testing, and evaluation of the developed questionnaire. 
The validation phase consisted of content validity, face validity, construct validity, exploratory 
factor analysis and test-retest method. Cronbach’s alpha was used to verify internal consistency. A 
revised final version was drafted. The knowledge segment consists of five questions, attitude 






There were 77 participants were enrolled. Twenty of them (26%) have mild intermittent, 32 
(41.6%) have mild persistent and 25 (32.5%) have moderate severe persistent AR. Ninety five 
percent indicated they understood the questions and found them easy to answer. Ninety percent 
indicated the appearance and layout were acceptable. Explanatory factor analysis revealed four 
factors associated with KAP. The Cronbach’s alpha of the four factors ranged from 0.614 and 
0.809. The final questionnaire composed of the knowledge segment consists of four questions, 
attitude segment consists of four questions and the practice segment consists of four questions was 
valid and reliable. 
 
Conclusions:  
The instrument has satisfactory reliability and validity indices and can be used to measure AR 
patients’ knowledge, attitude and practice regarding INCS usage. This study acts as a stepping stone 
towards deriving the KAP among AR patients to better understand and in turn improve treatment 
outcome by educating patients and rectifying their perception towards INCS usage.  
 






























Allergic rhinitis (AR) is an inflammatory disease of the nasal mucous membranes. An 
allergen exposure of allergic individuals results in an IgE-mediated inflammatory 
response, which can be manifested clinically as nasal congestion, postnasal drainage, 
rhinorrhea, nasal itching, sneezing, and itchy or watery eyes (1,2).   
The prevalence of AR is increasing worldwide, a trend that has been attributed to a 
variety of factors such as changing global climate conditions, improvements in hygiene, 
changes in diet, and increased obesity (1). Allergic rhinitis (AR) is a high-prevalence 
disease in many developed countries, affecting about 10±20% of the population. Several 
studies that have been done based on questionnaire, objective testing or medical 
examination indicate an increasing prevalence of AR in European countries over the last 
few decades (3). 
During the past several years, there has been a growing awareness of the importance of 
rhinitis in patients with bronchial asthma. Recent studies correlate worsening of asthma 
with the presence of severe rhinitis and clinical trials with variety of rhinitis treatment 
have shown significant beneficial effects in mild asthma (4). The uses of intranasal 
glucocorticosteroids are highly recommended for treatment of AR and it is the preferred 
treatment of choice over oral H1- antihistamines, oral leukotriene receptor antagonists, 
intranasal H1-antihistamines for patients with seasonal and persistent AR
 (5). 
Intranasal corticosteroids (INCS) are presently the most effective overall treatment for 
allergic rhinitis and are first-line therapy for adults in moderate-to-severe cases of 
allergic rhinitis or in individuals who are still symptomatic despite the regular use of 
antihistamines. Intranasal corticosteroid relieves all symptoms of allergic rhinitis, 
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including nasal blockage, and meta-analysis shows that are more effective than 
antihistamines (10, 11). 
There have been a number of studies on significant impact of patients’ quality of life 
(QOL), significant consequences of AR on emotional well-being productivity, and 
cognitive functioning. There is considerable economic burden that include direct and 
indirect costs caused by absenteeism and decreased productivity at school/work (6). 
AR has a significant negative impact on patients’ activities of daily living. Evidence 
suggests that a substantial number of AR sufferers did not receive medical care for their 
condition in the past year and/or have not been diagnosed with their condition. 
Although INCS are the most commonly prescribed AR treatment, less than half of 
patients are fully satisfied with their INCS. The majority of patients perceive that INCS 
lose effectiveness over a 24-hour period. The most common reasons for patients to 
discontinue treatment relate to lack of long-lasting symptom relief rather than side 
effects (1). 
In spite the clinical importance of INCS usage for AR patients, research in this area has 
been impeded by absence of a questionnaire devoted to an assessment of self-reported 



























 2.1 General objective: 
To develop and validate a new questionnaire evaluating the knowledge,  attitude and 
practice of AR patient towards intranasal  corticosteroids usage 
 
2.2 Specific objectives: 
 
1. To develop a new questionnaire evaluating the knowledge, attitude and practice of 
AR patient towards intranasal corticosteroids usage. 
 
2. To assess the validity of the new questionnaire evaluating the knowledge, attitude 
and practice of AR patient towards intranasal corticosteroids usage in terms of face 
validity, content validity and construct validity. 
 
3. To assess the reliability of the new questionnaire evaluating the knowledge, attitude 
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Development and validation of a questionnaire to assess the knowledge, attitude and 
practice (KAP) of allergic rhinitis (AR) patients towards intranasal corticosteroids use. 
Methods 
The questionnaire comprised development and validation stages. The questionnaire was 
developed after a comprehensive literature review.  It was subjected to content and face 
validity before a revised final version was drafted. It was given to patients for self-
administration. Exploratory factor analysis was used to assess the validity of the 
questionnaire. Cronbach’s alpha was used to verify internal consistency. 
Results 
The development phase resulted in a questionnaire consisting of 14 items. Explanatory 
factor analysis revealed four factors associated with KAP. The four factors were 
extracted and 12 items were kept. The factors were divided as attitude segment with 
four items (factor 1), practice segment with four items (factor 2) and knowledge 
segment with four items (factor 3 has two items and factor 4 has two items). The 
Cronbach’s alpha of the four factors ranged from 0.614 and 0.809. The final 
questionnaire consists of 3 domains with 12 items (the knowledge segment consists of 
four questions, attitude segment consists of four questions and the practice segment 





The newly developed questionnaire to measure KAP of AR patients towards the use of 
intranasal corticosteroids has adequate validity and reliability. It has an important role 
to improve the treatment of AR patients by understanding the factors affecting 
compliance of INCS usage. 

















Since the introduction of intranasal corticosteroids (INCS) in 1973 starting with 
beclomethasone, topical treatments have been successfully used in allergic rhinitis 
(AR). 1 Subsequently, numerous topical corticosteroids have been developed and 
marketed which includes flunisolide, budesonide, fluocortinbutyl, fluticasone 
propionate, triamcinolone acetonide and mometasone furoate. These INCS have a 
strong anti-inflammatory capacity in reducing mast cells to an extent, while reducing 
cytokine and chemokine release and can decrease the cellular infiltration of antigen-
presenting cells, eosinophils and T cells within the nasal mucosa. 1 
The use of INCS is highly recommended for treatment of AR and it is the preferred 
treatment of choice over oral H1-antihistamines, oral leukotriene receptor antagonists, 
intranasal H1-antihistamines for patients with seasonal and persistent AR. 
2,3 Intranasal 
corticosteroids are the most effective overall treatment for AR and are first-line therapy 
for adults in moderate-to-severe cases of AR or in individuals who are still symptomatic 
despite the regular use of antihistamines. 4,5 Regular prophylactic use of INCS is 
effective in reducing rhinorrhoea, nasal blockage, itching and sneezing in both children 
and adults.  
AR has been shown to have a significant negative impact on patients’ activities of daily 
living, their quality of life and affects their emotional well-being, productivity and 
cognitive functioning. 6 There is considerable economic burden that include direct and 
indirect costs caused by absenteeism and decreased productivity at school/work. 
Although INCS is the most commonly prescribed AR treatment by doctors, less than 
half of patients are fully satisfied with their INCS. Most patients perceived that INCS 
lose effectiveness over a 24-hour period. Some of the most common reasons for patients 
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to discontinue treatment relate to lack of long-lasting symptom relief rather than side 
effects. 7 Studies done on knowledge and attitude of nasal steroid perspective among 
physicians and non-AR patients, studies describing the attitude and practices on AR 
among different socioeconomic classes, studies on the physician’s opinion on the 
prevention and treatment of AR showed significant knowledge gap among attending 
physicians and patients. 8-10 Patients were not informed about the safety of INCS, 
compounding their worry of the possible side effects of INCS usage. 8-10 
Despite the benefit and the appreciation of the clinical importance of INCS usage for 
AR patients, research in this area has been impeded by the absence of a specific 
questionnaire devoted to an assessment of self-reported evaluation of knowledge, 
attitude and practice (KAP) of AR patients towards INCS usage. The knowledge gap 
and attitude of the patients that are prescribed the INCS adversely affects the outcome 
of their disease. The aim of this study was to develop a validated questionnaire to assess 
the KAP of AR patients towards INCS usage, to better interpret and overcome the 
shortfalls of treatment compliance and efficacy. 
3.4 METHODOLOGY 
Questionnaire development  
The questionnaire was developed after a comprehensive literature review. The 
preliminary version of the questionnaire consisted of 16 items was given to 8 
researchers and experts in the field (7 otorhinolaryngologists and 1 public health 
physician). They were asked to comment on the context and content of the items. Each 
reviewer independently rated the relevance of each item on each domain of the 
questionnaire to the conceptual framework using a 4-point Likert scale (1=not relevant, 
2=somewhat relevant, 3=relevant, 4=very relevant). The Content Validity Index (CVI) 
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was used to estimate the validity of the items whereby a rating of three or four indicates 
the content is valid and consistent with the conceptual framework. 11 For example, if 
five of eight content experts rate an item as relevant (3 or 4) the CVI would be 
5/8=0.62, which does not meet the 0.87 (7/8) level required, and implies that the item 
should be dropped. 11 This questionnaire was further pre-tested with 20 AR patients at 
another hospital not involved in this study whereby the participants were asked to 
answer as well as highlight ambiguous or problematic items by rating each items on a 
Likert scale of 1 to 4 (strongly disagree= 1, disagree= 2, agree= 3, and strongly agree= 
4). This served to test the face validity of the questionnaire, to assess how meaningful 
the concepts were to the studied community, the clarity of the wordings and the 
likelihood the target audience would be able to answer the questions.  The layout and 
appearance of the questions were modified based on the face validation. A revised final 
version of the KAP towards INCS (KAP-INCS) questionnaire consisting of 14 items 
was drafted and used. The KAP-INCS questionnaire was divided into two sections, the 
demographic data and KAP towards INCS usage. The demographic section consists of 
seven questions such as age, gender, ethnicity, residency, education qualifications, the 
year of diagnosis and the year nasal spray was prescribed. The second section was the 
assessment of the KAP towards INCS usage among AR patients. The knowledge 
segment consists of five questions, attitude segment consists of five questions and the 
practice segment consists of four questions. For the knowledge segment, dichotomous 
response of ‘yes’ and ‘no’ was administered with a choice of ‘not sure’ added. Likert-
scale questions were used to collect data regarding their attitude and practice. The 
attitude segment consists of six ordered score being ‘totally disagree, disagree, quite 
disagree, quite agree, agree and totally agree’. The practice segment consists of five 
ordered score being ‘almost never, rarely, sometimes, almost always and always’. 
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Study setting and participants 
The final version of KAP-INCS was given to patients at two tertiary hospitals (Kelantan 
and Penang) in Malaysia from April 2017 till December 2017 for self-administration. 
The selected patients were above 15 years old of age, who were able to read and write 
in English, previously diagnosed as AR and being treated by INCS. Patients with self-
diagnosed AR and on self-medicated nasal sprays were excluded from this study. 
Sample size was determined using factor analysis method with a subject-to-variable 
ratio of 1:5. 12 Consent was obtained, and anonymity of the participants was maintained. 
The study protocol was reviewed and approved by the Human Research Ethics 
Committee of USM and Medical Research and Ethics Committee of Ministry of Health 
Malaysia and was performed in adherence with the Declaration of Helsinki. 
Validation of questionnaire 
The exploratory factor analysis and Cronbach’s alpha were used to measure construct 
validity and internal consistency of the KAP-INCS questionnaire. 13 The factor analysis, 
Kaiser-Meyer-Olkin test (KMO) and Bartlett’s test of sphericity were computed to 
identify the items to be included in the final analysis. A typical factor analysis was 
performed based on Pearson correlations since the Likert scale could be treated as an 
interval or ratio scale. Principal axis factoring with rotation method of promax with 
Kaiser’s normalization and scree plot inspection was used to determine the number of 
factors to retain. According to Kaiser's criterion, all factors with eigenvalues < 1 are 
dropped. Secondly, the factor analysis was repeated by including and excluding each 
item until the best combination or reduction was met. Lastly, the factor analysis was 
again computed to produce factor loading for the final version of the questionnaire. 11 
Factor loadings > 0.5 and communalities of > 0.25 were considered acceptable. In 
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general, correlations of <0.85 between factors are expectable in health sciences. 14 Once 
the validity procedures were completed, the final version of the KAP-INCS 
questionnaire was examined to assess its reliability.  For internal consistency reliability, 




Continuous variables were reported as the mean value ± standard deviation (SD). 
Bartlett's test for sphericity was to test the appropriateness of the factor model while the 
KMO measure of Sampling Adequacy was to test whether the partial correlations 
among variables were small. The KMO statistic ranged between 0 and 1. 15 KMO value 
close to 1 indicates the sample efficiency and justifiability for factor analysis. From the 
Pearson’s correlation matrix, items that show weak correlation with others would be 
removed. Cronbach’s alpha coefficient was used as an estimate of the internal 
consistency of the questionnaire. 
 
3.5 RESULTS 
Seventy-seven patients consisting of 39 males and 38 females enrolled in this study. 
The age ranged from 15 to 77 years with a mean age of 36.74. In terms of ancestry, 
there were 29 Malays (37.7%), 26 Chinese (33.8%), 18 Indian (23.4%) and 4 (5.2%) 
others, representing local ethnic ratio (Table 1). Their educational background was 2 
(2.6%) with either doctor of philosophy or master, 42 (54.5%) with bachelor degree, 9 
(11.7%) with diploma and 24 (31.2%) with secondary school certificate. The severity of 
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AR according to ARIA guidelines 3 showed 20 (26%) have mild intermittent, 32 
(41.6%) have mild persistent and 25 (32.5%) have moderate severe persistent. There 
was no moderate severe intermittent AR.  
Content Validity 
Based on the comments of the experts, 2 items were deleted as they were ambiguous 
and did not serve to answer any clinical relevance to the objective of this study. 
Fourteen items remained consisting of 5 items in knowledge domain, 5 items in attitude 
domain and 4 items in practice domain.  One item on the draft was deemed to be 
inappropriate because it yielded CVI of 4 / 8 = 0.5 and was removed and replaced in the 
questionnaire. That item was Q1 from the knowledge domain, “I recognize the 
importance of using nasal steroid” and was replaced by “I am aware of the importance 
of using nasal steroid” (CVI of 8 / 8 = 1.0). All the remaining items were valid with 
CVI ranging from 0.87 (7 / 8) to 1.0 (8 / 8) and were retained. 
Face validity 
All 20 pretested participants rated each parameter at three or four on a Likert scale of 1 
to 4. Ninety five percent indicated they understood the questions and found them easy 
to answer, and 90% indicated the appearance and layout would be acceptable to the 
intended target group. The remaining items of the questionnaire that underwent 
statistical analysis after content and face validity, along with their descriptive statistics, 
are as shown in Table 2, Table 3 and Table 4.  
Factor analysis 
KMO measure of sampling adequacy was 0.655 (> 0.5) and Bartlett's test of sphericity 
was appropriate. Thus, a satisfactory factor analysis could proceed. The exploratory 
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factorial analysis showed four factors with eigenvalue of more than one. This was 
supported by scree plot which also indicated 4 factors. On the first run of exploratory 
factor analysis (EFA), the question A-Q2 was marked for deletion as the communalities 
was 0.223 which was < 0.25. Next the question K-Q1 showed a factor loading of < 0.5 
with communalities < 0.25 and was deleted. Then, item extraction and another run of 
EFA were done. All items showed communalities > 0.25. All factors loading were > 0.5 
except for P-Q3 (0.35). All factors correlation coefficient was < |0.85|. However, item 
P-Q3 was accepted because we deemed it as important to the relevant domain and has 
significant clinical value in determining the practices of the patient. The four factors 
were extracted, and 12 items were kept. The factors were divided as factor 1 (A-Q1, A-
Q3, A-Q4, A-Q5); factor 2 (P-Q1, P-Q2, P-Q3, P-Q4); factor 3 (K-Q2, KQ3) and factor 
4 (K-Q4, K-Q5). Factor correlation (r) ranged from 0.102 to 0.345. The knowledge 
domain was divided into two factors with items K-Q2 and K-Q3 in one factor (factor 3) 
and items K-Q4 and K-Q5 in another factor ( factor 4) as per the Kaiser’s eigenvalue >1 
rule and the factors correlation <0.85.  
Internal consistency 
The Cronbach’s alpha was calculated for each factor. The Cronbach’s alpha for factor 1 
was 0.809, factor 2 was 0.774, factor 3 was 0.735 and factor 4 was 0.614. Even though 
factor 4 was less than 0.65, for an exploratory research it was considered marginally 
acceptable reliability 16 and factor 4 was kept in the questionnaire. The final 
questionnaire consists of 3 domains with 12 items, the knowledge segment consists of 
four questions, attitude segment consists of four questions and the practice segment 




The prevalence of AR is increasing worldwide, a trend that has been attributed to a 
variety of factors such as changing global climate conditions, improvements in hygiene, 
changes in diet and increased obesity. 7 Although INCS is proven to be efficacious for 
seasonal and perennial allergic rhinitis, patients are still not fully satisfied with their 
INCS treatment.  Poor knowledge and practice pattern among patients towards AR and 
the causative allergens could be the contributing factors. 17 There was poor awareness of 
AR among diagnosed and undiagnosed patients and the knowledge about risk of asthma 
in AR patients was found to be inadequate. 18  
This study provides an assessment on the validity and reliability of a newly developed 
KAP-INCS questionnaire to assess KAP of AR patients on their INCS usage. 
Validation of this set of questionnaires which includes content validity, face validity, 
reliability and factor analysis, is important because it helps physicians to understand the 
factors affecting compliance of INCS usage in order for them to improve the treatment 
of their AR patients.   It is short and easily understood by patient but covers pertinent 
questions towards assessing their KAP. Content validity was determined after a review 
was obtained from the experts in the field. The three domains consist of 16 questions 
initially which was reduced to 14 questions after the content validation. The layout and 
appearances of the questions were modified after the face validation by pretesting with 
20 AR patients. Finally, the 3 domains had 12 questions with 4 factors. 
The knowledge domain of K-Q2 and K-Q3 (factor 3)  showed a Cronbach’s alpha of 
0.735, which was respectable. The factor with K-Q4 and K-Q5 (factor 4) showed a 
Cronbach’s alpha of 0.614 and deemed as marginally acceptable reliability in an 
exploratory research. 16 The attitude domain had one factor consisting of items A-Q1, 
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A-Q3, A-Q4, A-Q5 that had a Cronbach’s alpha of 0.809, which was very good. The 
practice domain had one factor as well with items P-Q1, P-Q2, P-Q3, P-Q4 had a 
Cronbach’s alpha of 0.774 (Table 5).  Our data showed the newly developed KAP-
INCS questionnaire had a good internal consistency and reproducibility. The 
exploratory factorial analysis in our study showed four factors, in which the items 
weighed down on a given factor had some shared conceptual meaning and on the other 
side, the items in different factors measure different concepts. Also, high correlation 
between items in each of the factors showed their congruence.  
Based on content experts’ decision (NS, AFI, BA), factor 3 and factor 4 were combined 
to represent the knowledge domain. Expert opinion is valuable and allowed to combine 
factors if it answers the objective of a study. Although the Kaiser criterion is to select 
those factors that have an eigenvalue >1, the general criterion of an eigenvalue > 1 
could misrepresent the most appropriate number of factors 19 and Kaiser's criterion is 
also known for its tendency to over-extract factors. 20 Therefore, ultimately based on 
content experts’ opinion, we adopted a less stringent approach, in order to reach an 
informative but relatively parsimonious model by combining factor 3 and factor 4 to 
represent the knowledge domain (Table 6).  
Conclusions 
Our newly developed KAP-INCS questionnaire proved to be a reliable and valid tool to 
measure KAP among AR patients towards INCS usage. Understanding their KAP helps 
health-care providers to target patients and problem areas that need interventions with 
the ultimate goal of preventing the significant consequences of AR on their emotional 
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Table 1. Socio-demographic characteristic of patients (n =77). 
 
               Mean (SD)                                       N (%) 


































Aria diagnosis:  
Mild intermittent 
Mild persistent  
Moderate severe 















Mean (SD) Yes (n %) Not sure (n 
%) 
No (n %) 
K-Q1 I am aware of the importance of 
using nasal steroid 
 
1.62 (0.69) 57 (74.0) 11 (14.3) 9 (11.7) 
K-Q2 Nasal spray contains steroid 
 
1.49 (0.64) 44 (57.1) 27 (35.1) 6 (7.8) 
K-Q3 Nasal steroid has long term side 
effects     








K-Q4 Nasal steroid is an effective 
treatment for allergic rhinitis   
                     
1.61 (0.59) 51 (66.2) 22 (28.6) 4 (5.2) 
K-Q5 I know the correct method of 
using the nasal steroid 
 
















Table 3. Descriptive statistics of the items in the attitude domain.  
 



















A-Q1 Allergic rhinitis 
is a disease I 
























A-Q3 It is important 












































Table 4. Descriptive statistics of the items in the practice domain.  
 
























P-Q2 I use the nasal steroid daily 








P-Q3 I use other prescribed 








P-Q4 I follow the dosage and 





3(3.9) 4(5.2) 16(20.8) 30 
(39) 
24 
(31.2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
